New oral anticoagulants: key messages for clinicians
New oral anticoagulants are an effective and safe alternative to vitamin K antagonists in many fields of clinical practice. The use of the direct inhibitors of activated Factor II (dabigatran) and activated Factor X (apixaban and rivaroxaban), both in patients with non-valvular atrial fibrillation (...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2013-12-01
|
| Series: | Italian Journal of Medicine |
| Subjects: | |
| Online Access: | http://www.italjmed.org/index.php/ijm/article/view/465 |
| _version_ | 1827613002732404736 |
|---|---|
| author | Matteo Giorgi-Pierfranceschi Chiara Cattabiani Francesco Dentali |
| author_facet | Matteo Giorgi-Pierfranceschi Chiara Cattabiani Francesco Dentali |
| author_sort | Matteo Giorgi-Pierfranceschi |
| collection | DOAJ |
| description | New oral anticoagulants are an effective and safe alternative to vitamin K antagonists in many fields of clinical practice. The use of the direct inhibitors of activated Factor II (dabigatran) and activated Factor X (apixaban and rivaroxaban), both in patients with non-valvular atrial fibrillation (NVAF) and those with acute venous thromboembolism (VTE), is of great interest for internal medicine physicians. This paper aims to give practical guidance on management (starting therapy, follow up and bleeding complications) of patients treated with dabigatran, rivaroxaban or apixaban for NVAF or acute VTE providing practical tables concerning the phases of therapy, management of complications, drug interaction and dose adjustment if renal impairment occurs. |
| first_indexed | 2024-03-09T08:33:29Z |
| format | Article |
| id | doaj.art-06f0b7cba8bd4aefa42a22c25fd585ef |
| institution | Directory Open Access Journal |
| issn | 1877-9344 1877-9352 |
| language | English |
| last_indexed | 2024-03-09T08:33:29Z |
| publishDate | 2013-12-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Italian Journal of Medicine |
| spelling | doaj.art-06f0b7cba8bd4aefa42a22c25fd585ef2023-12-02T19:03:27ZengPAGEPress PublicationsItalian Journal of Medicine1877-93441877-93522013-12-0178S748410.4081/itjm.2013.s8.74392New oral anticoagulants: key messages for cliniciansMatteo Giorgi-Pierfranceschi0Chiara Cattabiani1Francesco Dentali2Emergency Department, Hospital of val d'Arda, PiacenzaEmergency Department, Hospital of val d'Arda, PiacenzaInternal Medicine Department, University of Insubria, VareseNew oral anticoagulants are an effective and safe alternative to vitamin K antagonists in many fields of clinical practice. The use of the direct inhibitors of activated Factor II (dabigatran) and activated Factor X (apixaban and rivaroxaban), both in patients with non-valvular atrial fibrillation (NVAF) and those with acute venous thromboembolism (VTE), is of great interest for internal medicine physicians. This paper aims to give practical guidance on management (starting therapy, follow up and bleeding complications) of patients treated with dabigatran, rivaroxaban or apixaban for NVAF or acute VTE providing practical tables concerning the phases of therapy, management of complications, drug interaction and dose adjustment if renal impairment occurs.http://www.italjmed.org/index.php/ijm/article/view/465new oral anticoagulants, internal medicine, management checklist. |
| spellingShingle | Matteo Giorgi-Pierfranceschi Chiara Cattabiani Francesco Dentali New oral anticoagulants: key messages for clinicians Italian Journal of Medicine new oral anticoagulants, internal medicine, management checklist. |
| title | New oral anticoagulants: key messages for clinicians |
| title_full | New oral anticoagulants: key messages for clinicians |
| title_fullStr | New oral anticoagulants: key messages for clinicians |
| title_full_unstemmed | New oral anticoagulants: key messages for clinicians |
| title_short | New oral anticoagulants: key messages for clinicians |
| title_sort | new oral anticoagulants key messages for clinicians |
| topic | new oral anticoagulants, internal medicine, management checklist. |
| url | http://www.italjmed.org/index.php/ijm/article/view/465 |
| work_keys_str_mv | AT matteogiorgipierfranceschi neworalanticoagulantskeymessagesforclinicians AT chiaracattabiani neworalanticoagulantskeymessagesforclinicians AT francescodentali neworalanticoagulantskeymessagesforclinicians |